Arya Resources Ltd. — Proxy Solicitation & Information Statement 2026

Apr 1, 2026

NERVGEN PHARMA CORP.
112-970 Burrard Street, Unit 1290, Vancouver, BC V6Z 2R4

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN THAT the annual meeting (the “Meeting”) of shareholders of NervGen Pharma Corp. (the “Corporation”) will be held at 199 Bay St. #4000, Toronto, ON M5L 1A9, on Thursday, April 23, 2026, at 3:00 p.m. (Eastern time), for the following purposes:

1. to receive the consolidated financial statements of the Corporation for its fiscal year ended December 31, 2025, the report of the auditor thereon and related management’s discussion and analysis;
2. to set the number of directors for the ensuing year at eight (8);
3. to elect the directors of the Corporation for the ensuing year;
4. to appoint the auditor of the Corporation for the ensuing year and to authorize the directors to fix the auditor’s remuneration;
5. to consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution of shareholders approving the adoption of a new omnibus equity incentive plan of the Corporation;
6. to consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution of shareholders approving amendments to the Stock Option Plan of the Corporation;
7. to consider, and if deemed advisable, to pass, with or without variation, a special resolution to approve and adopt certain amendments to the Corporation’s Articles of Incorporation; and
8. to transact such other business as may properly come before the Meeting or any adjournment thereof.

The specific details of the matters proposed to be put before the Meeting is set forth in the Management Proxy Circular which accompanies this Notice of Meeting.

---

DATED at Vancouver, British Columbia this 13th day of March, 2026.

BY ORDER OF THE BOARD OF DIRECTORS

“Adam Rogers”

Adam Rogers
Chairperson

NOTES:

(1) A Management Proxy Circular and Proxy accompany this Notice of Meeting. Registered shareholders who are unable to be present at the Meeting are kindly requested to specify on the accompanying form of proxy the manner in which the shares represented thereby are to be voted, and to sign, date, and return same in accordance with the instructions set out in the Proxy and the Management Proxy Circular.

(2) As provided in the Business Corporations Act (British Columbia), the directors have fixed a record date of March 13, 2026. Accordingly, persons who are registered as shareholders on the books of the Corporation at the close of business on March 13, 2026, are entitled to notice of the Meeting.

(3) If you are a non-registered shareholder and receive these materials through your broker or another intermediary, please complete and return the materials in accordance with the instructions provided to you by your broker or intermediary.

• ii -